• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗胸腺细胞球蛋白治疗后再生障碍性贫血的克隆缓解

Clonal remission in aplastic anemia after treatment with antithymocyte globulin.

作者信息

Wun T, Lewis J P

机构信息

Department of Medicine and Pathology, University of California Davis Medical Center, Sacramento.

出版信息

Am J Hematol. 1992 Jul;40(3):229-31. doi: 10.1002/ajh.2830400314.

DOI:10.1002/ajh.2830400314
PMID:1609778
Abstract

Aplastic anemia includes a group of disorders characterized by peripheral blood pancytopenia and marrow hypocellularity. The current report describes a patient who is an apparent constitutional mosaic and presented with marrow aplasia. Using cytogenetic analysis of bone marrow, skin, and peripheral T lymphocytes, we demonstrated the clonal nature of this patient's aplastic marrow, and, in addition, identify clonal evolution. The patient was treated with antithymocyte globulin (ATG) and achieved a complete remission, with disappearance of an abnormal evolved clone. This case illustrates that clonal cytogenetic abnormalities do not preclude a response to ATG and that aplastic anemia may be a nonmalignant clonal disorder with clonal evolution.

摘要

再生障碍性贫血包括一组以外周血全血细胞减少和骨髓细胞减少为特征的病症。本报告描述了一名明显为体质性嵌合体且出现骨髓发育不全的患者。通过对骨髓、皮肤和外周T淋巴细胞进行细胞遗传学分析,我们证实了该患者再生障碍性骨髓的克隆性质,此外,还识别出了克隆演变。该患者接受了抗胸腺细胞球蛋白(ATG)治疗并实现了完全缓解,异常演变的克隆消失。本病例表明,克隆性细胞遗传学异常并不排除对ATG的反应,且再生障碍性贫血可能是一种具有克隆演变的非恶性克隆性疾病。

相似文献

1
Clonal remission in aplastic anemia after treatment with antithymocyte globulin.抗胸腺细胞球蛋白治疗后再生障碍性贫血的克隆缓解
Am J Hematol. 1992 Jul;40(3):229-31. doi: 10.1002/ajh.2830400314.
2
Aplastic anemia associated with bone marrow suppressor T-cell hyperactivity: successful treatment with antithymocyte globulin.与骨髓抑制性T细胞活性亢进相关的再生障碍性贫血:抗胸腺细胞球蛋白治疗成功
Am J Hematol. 1978;5(1):25-32. doi: 10.1002/ajh.2830050104.
3
[Effectiveness of antilymphocyte and antithymocyte globulins for patients with severe aplastic anemia and pure red cell aplasia--analysis of immunologic parameters of peripheral lymphocytes concerning ALG and ATG therapy].抗淋巴细胞球蛋白和抗胸腺细胞球蛋白治疗严重再生障碍性贫血和纯红细胞再生障碍性贫血患者的疗效——关于抗淋巴细胞球蛋白(ALG)和抗胸腺细胞球蛋白(ATG)治疗的外周淋巴细胞免疫参数分析
Rinsho Ketsueki. 1990 Jan;31(1):10-5.
4
Antithymocyte globulin treatment of severe aplastic anaemia.抗胸腺细胞球蛋白治疗重型再生障碍性贫血。
Br J Haematol. 1983 Sep;55(1):17-25. doi: 10.1111/j.1365-2141.1983.tb01220.x.
5
Severe aplastic anaemia with complete autologous marrow reconstitution following treatment with antithymocyte globulin. Report of a case and review of the literature.抗胸腺细胞球蛋白治疗后严重再生障碍性贫血完全自体骨髓重建。1例报告并文献复习。
Scand J Haematol. 1978 Jul;21(1):14-8. doi: 10.1111/j.1600-0609.1978.tb02489.x.
6
Intravenous immunoglobulin in the treatment of aplastic anemia.静脉注射免疫球蛋白治疗再生障碍性贫血。
Am J Pediatr Hematol Oncol. 1990 Summer;12(2):198-200. doi: 10.1097/00043426-199022000-00014.
7
Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation.接受抗胸腺细胞球蛋白治疗的成人再生障碍性贫血的长期预后:与骨髓移植的比较。
Blood. 1995 Jan 1;85(1):283-90.
8
[Treatment of aplastic anemia with antithymocyte globulin].
Harefuah. 1990 Jan 15;118(2):72-4.
9
Gold-induced bone marrow aplasia: successful treatment with antithymocyte globulin.
Aust N Z J Med. 1985 Apr;15(2):253-5. doi: 10.1111/j.1445-5994.1985.tb04018.x.
10
Re-treatment of aplastic anemia with antithymocyte globulin or antilymphocyte serum.用抗胸腺细胞球蛋白或抗淋巴细胞血清对再生障碍性贫血进行再治疗。
Am J Med. 1988 Apr;84(4):678-82. doi: 10.1016/0002-9343(88)90104-0.